Crosslink Capital, Inc. (“Crosslink”) was recently informed that someone or an organization has been impersonating it and one or more of its employees on the mobile application WhatsApp.
Crosslink does not market its services and Crosslink and its employees do not provide investment advice through WhatsApp or any similar social media messaging application, and anyone who does so purporting to act in Crosslink’s name or the name of any of its employees is not in any way connected to Crosslink or Crosslink Capital Management, LLC. Crosslink employees provide investment advice only through Crosslink. Crosslink provides investment advice only to investment funds or clients, in each case, with whom it has entered into a written contract. Crosslink does not provide investment or other advice to non-clients.
You can look up investment advisers and their registered persons at: https://adviserinfo.sec.gov/
For more information investing generally, please see: https://www.investor.gov/
March 01, 2022
MEDFORD, Mass. — OPT Industries (www.optindustries.com), the manufacturing technology startup behind the InstaSwab™ high-efficacy medical applicator, today announced it has raised $15 million in Series A financing led by global science- and technology-driven venture capital firm Northpond Ventures with participation from existing investors Crosslink Capital and the MIT-affiliated E14 Fund.
OPT’s proprietary additive manufacturing system — built upon over seven years of R&D in 3D printing and computational fabrication at MIT— enables the 3D printing of continuous materials and products at unlimited lengths with micron-level precision. At the heart of the system is RAMP™, OPT’s flagship technology and the world’s first roll-to-roll 3D printing platform.
“As an advanced manufacturing company, we see the value in building micro-scale technologies that solve macro-scale challenges,” said Jifei Ou, founder and CEO of OPT. “OPT works with customers to design and manufacture a novel range of metamaterials and products for the healthcare, automotive, cosmetics and consumer goods industries, and beyond. We will leverage the new financing to address the demand for InstaSwab™, fuel product development, scale operations and grow the team.” Read rest here.